AbbVie
ABBV
ABBV
1,796 hedge funds and large institutions have $99.5B invested in AbbVie in 2017 Q3 according to their latest regulatory filings, with 122 funds opening new positions, 596 increasing their positions, 824 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
2% more funds holding
Funds holding: 1,762 → 1,796 (+34)
0.86% more ownership
Funds ownership: 69.41% → 70.27% (+0.86%)
28% less repeat investments, than reductions
Existing positions increased: 596 | Existing positions reduced: 824
Holders
1,796
Holding in Top 10
160
Calls
$1.25B
Puts
$1.07B
Top Buyers
| 1 | +$896M | |
| 2 | +$818M | |
| 3 | +$466M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$346M |
| 5 |
BlackRock
New York
|
+$345M |
Top Sellers
| 1 | -$607M | |
| 2 | -$342M | |
| 3 | -$267M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$240M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$186M |